| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 90.7% | 39/43 |
| Female | 9.3% | 4/43 |
| Indifferent | 0% | 0/43 |
| Unknown | 0% | 0/43 |
| General | ||
| 23.3% | 10/43 | |
| 23.3% | 10/43 | |
| 23.3% | 10/43 | |
| 25.6% | 11/43 | |
| 20.9% | 9/43 | |
| 59.5% | 25/42 | |
| 97.7% | 42/43 | |
| 100% | 41/41 | |
| 92.9% | 39/42 | |
| 93% | 40/43 | |
| Neurology | ||
| 97.7% | 42/43 | |
| 73.8% | 31/42 | |
| 58.1% | 25/43 | |
| Facial abnormalities | ||
| 74.4% | 32/43 | |
| 88.4% | 38/43 | |
| 67.4% | 29/43 | |
| 81.4% | 35/43 | |
| Visual and hearing impairments | ||
| 41.9% | 18/43 | |
| 34.9% | 15/43 | |
| Heart | ||
| 39.5% | 17/43 | |
| Gastrointestinal | ||
| 69.8% | 30/43 | |
| Urogenital | ||
| 30.2% | 13/43 | |
| Skeleton | ||
| 95.3% | 41/43 | |
| Skin / Hair / Nails | ||
| 51.2% | 22/43 | |
| Endocrine / Immunological / Metabolic | ||
| 7% | 3/43 | |
| 46.5% | 20/43 | |
| 4.7% | 2/43 | |
| Neoplasia | ||
| 2.3% | 1/43 | |
| Inheritance | ||
| 97.5% | 39/40 | |
TAF1